| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/03/2008 | WO2007089626A3 Anabaseine derivatives, pharmaceutical compositions and methods of use thereof |
| 01/03/2008 | WO2007088421A3 A process for the removal of sterols and other compounds from glycerol oils |
| 01/03/2008 | WO2007084541A3 Central administration of stable formulations of therapeutic agents for cns conditions |
| 01/03/2008 | WO2007082922A8 Long term treatment of hiv- infection with tcm278 |
| 01/03/2008 | WO2007081901A3 Pyrimidinone derivatives as protein kinase inhibitors |
| 01/03/2008 | WO2007070866A3 Control of intraocular pressure using alk5 modulation agents |
| 01/03/2008 | WO2007067752A3 Certain compositions and methods of treatment |
| 01/03/2008 | WO2007066201A3 Chemical compounds |
| 01/03/2008 | WO2007063286A3 Amidine derivatives for in vivo imaging |
| 01/03/2008 | WO2007061677A3 Spirolactam aryl cgrp receptor antagonists |
| 01/03/2008 | WO2007060491A3 Pharmaceutical compositions comprising a sodium channel blocker in combination with a mao-b- inhibitor |
| 01/03/2008 | WO2007058879A3 Inhibitors of akt activity |
| 01/03/2008 | WO2007056392A3 Polycationic viscoelastic compositions |
| 01/03/2008 | WO2007056170A3 Pyrrolo[2,1-f] [1,2,4] triazin-4-ylamines igf-1r kinase inhibitors for the treatment of cancer and other hyperproliferative diseases |
| 01/03/2008 | WO2007047553A3 Methods and compositions for treatment of prostate intraepithelial neoplasia |
| 01/03/2008 | WO2007041358A8 Substituted pyrazole compounds |
| 01/03/2008 | WO2007026261A3 Formulations containing losartan and/or its salts |
| 01/03/2008 | WO2007024971A3 Hedgehog pathway antagonists to treat disease |
| 01/03/2008 | WO2007019111A3 Cyclic ketal beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/03/2008 | WO2007006581A3 Targeting lsd1 for use in identifying and/or scoring prostate cancer and for controlling anrogen receptor-dependent gene expression |
| 01/03/2008 | WO2006104915A9 8-PHENYL-7,8-DIHYDROPYRIDO[2,3-d]PYRIMIDIN-7-ONES AND THEIR USE AS PHARMACEUTICALS |
| 01/03/2008 | WO2006034321A3 Oligomeric compounds effecting drosha-mediated cleavage |
| 01/03/2008 | WO2005123131A3 High pressure spray-dry of bioactive materials |
| 01/03/2008 | WO2005021040A3 Compositions useful for treating gastrointestinal motility disorders |
| 01/03/2008 | WO2005019200A3 Aryl piperidine derivatives as vla-1 integrin antagonists and uses thereof |
| 01/03/2008 | WO2004022039A3 Use of guanosine or inosine as anti-apoptotic agents in the treatment of i. a. neurodegenerative diseases or injuries at the nervous system |
| 01/03/2008 | WO2003085085A3 Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen |
| 01/03/2008 | WO2002053143A3 Treatment of erectile dysfunction with rho-kinase inhibitors |
| 01/03/2008 | US20080004613 Methods and devices for treatment of migraines |
| 01/03/2008 | US20080004450 cyclization; deprotecting; treatment of cancer and cancer which has developed multidrug-resistant phenotype |
| 01/03/2008 | US20080004398 Bioactive Biomaterials for Controlled Delivery of Active Principles |
| 01/03/2008 | US20080004368 biocompatible, bioresorbable, injectable, in-situ hardening scaffold for tissue engineering; self-crosslinkable and photocrosslinkable; better mechanical strength and self-crosslinking characteristics than polycaprolactone fumarate homopolymer; bone regeneration; hydroxyapatite filler |
| 01/03/2008 | US20080004354 Compositions containing aromatic aldehydes and their use in treatment |
| 01/03/2008 | US20080004353 Administration of 2-propanone-1,3,5,5-trimethyl-2-cyclohexen-1-ylidine or its isomers, salts or solvates for therapy of epilepsy or seizures |
| 01/03/2008 | US20080004352 serotonin (5-HT2C) receptor antagonist; antidepressant, anxiolytic agent; seasonal affective disorders, sleep disorders, cardiovascular pathologies, pathologies of the digestive system, insomnia and fatigue resulting from jetlag, appetite disorders and obesity |
| 01/03/2008 | US20080004351 Using metal hydrogenation catalyst in trickel bed reractor |
| 01/03/2008 | US20080004350 2-Fluoro-N-[3-hydroxy-2-(7-methoxy-1-naphthyl)propyl]acetamide, its enantiomers, and addition salts; melatoninergic disorders, circadian rhythm disorders, antidepressants, seasonal affective disorders, sleep disorders, jetlag |
| 01/03/2008 | US20080004349 Naphthalene compounds |
| 01/03/2008 | US20080004348 Naphthalene compounds |
| 01/03/2008 | US20080004347 serotonin (5-HT2C) receptor antagonist; antidepressant, anxiolytic agent; seasonal affective disorders, sleep disorders, cardiovascular pathologies, pathologies of the digestive system, insomnia and fatigue resulting from jetlag, appetite disorders and obesity |
| 01/03/2008 | US20080004346 Methods and Compositions for Treatment of Intraepithelial Neoplasia |
| 01/03/2008 | US20080004345 Novel Water-Soluble Fullerene, Process for Producing the Same and Active Oxygen Generator Containing the Fullerene |
| 01/03/2008 | US20080004344 Novel Salts of Fumaric Acid Monoalkylesters and Their Pharmaceutical Use |
| 01/03/2008 | US20080004343 Stable polymorphs of (E)-N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide |
| 01/03/2008 | US20080004342 Fatty acid phenolic conjugates |
| 01/03/2008 | US20080004341 Immunotherapeutic Agent |
| 01/03/2008 | US20080004340 Cationic Cassia Derivatives and Applications Therefor |
| 01/03/2008 | US20080004338 Use of enantiomeric pure escitalopram |
| 01/03/2008 | US20080004337 Therapeutic Agent for Substance Dependence |
| 01/03/2008 | US20080004336 Crystal structures of sglt2 inhibitors and processes for preparing same |
| 01/03/2008 | US20080004335 Athletic Ability Enhancing Composition |
| 01/03/2008 | US20080004334 Thiolactones |
| 01/03/2008 | US20080004333 Ion channel modulating compounds and uses thereof |
| 01/03/2008 | US20080004332 Methods for alzheimer's disease treatment and cognitive enhancement |
| 01/03/2008 | US20080004331 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |
| 01/03/2008 | US20080004330 Aminomethyl-Azacycle Derivatives as Inhibitors of Monoamine Uptake |
| 01/03/2008 | US20080004329 Pharmaceutical compositions of ropinirole and methods of use thereof |
| 01/03/2008 | US20080004328 Fused heterocycles |
| 01/03/2008 | US20080004327 Fluoro-substituted inhibitors of d-amino acid oxidase |
| 01/03/2008 | US20080004326 Method of Obtaining Idolocarbazoles Using Biosynthetic Rebeccamycin Genes |
| 01/03/2008 | US20080004325 PTP1B inhibitors |
| 01/03/2008 | US20080004324 Methods of preventing weight gain |
| 01/03/2008 | US20080004322 Methods of food intake management |
| 01/03/2008 | US20080004321 Potentiators of Glutamate Receptors |
| 01/03/2008 | US20080004320 Remedy for Glomerular Disease |
| 01/03/2008 | US20080004319 Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole |
| 01/03/2008 | US20080004318 Substituted Bicyclic and Tricyclic Thrombin Receptor Antagonists |
| 01/03/2008 | US20080004317 Compounds |
| 01/03/2008 | US20080004316 Novel aminopyridine derivatives as mGluR5 antagonists |
| 01/03/2008 | US20080004315 Guanidine Derivatives and Therapeutic Uses Thereof |
| 01/03/2008 | US20080004314 Phenylpiperidines and Phenylpyrrolidines |
| 01/03/2008 | US20080004313 Preparation of crystalline polymorphs of rimonabant hydrochloride |
| 01/03/2008 | US20080004312 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists |
| 01/03/2008 | US20080004311 Histone deacetylase inhibitors for treating degenerative diseases of the eye |
| 01/03/2008 | US20080004310 Lyophilized pharmaceutical composition |
| 01/03/2008 | US20080004309 [(2-bromo-4-hydroxy-1-phenyl-1H-pyrrolo[2,3-c]pyridine-5-carbonyl)-amino]-acetic acid; modulates the stability and/or activity of hypoxia inducible factor (HIF) |
| 01/03/2008 | US20080004308 Azaindole inhibitors of aurora kinases |
| 01/03/2008 | US20080004307 Azaindoles Having Serotonin Receptor Affinity |
| 01/03/2008 | US20080004306 Compositions and methods for modulating gated ion channels |
| 01/03/2008 | US20080004305 Intranasal Opioid Compositions |
| 01/03/2008 | US20080004304 Aryl Spirolactam Cgrp Receptor Antagonists |
| 01/03/2008 | US20080004303 Combination of Itriglumide and Proton Pump Inhibitors in the Treatment of Gastrointestingal and Related Disorders |
| 01/03/2008 | US20080004302 Novel Compounds |
| 01/03/2008 | US20080004301 Benzene Compound Having 2 or More Substituents |
| 01/03/2008 | US20080004300 protein kinase inhibitors such as N-[5-(4,4-Dimethyl-2,5-dioxo-3-pyridin-4-ylmethyl-imidazolidin-1-yl)-2-trifluoromethoxy-phenyl]-2-morpholin-4-yl-acetamide, used for treating tumors; antitumor and anticarcinogenic agents |
| 01/03/2008 | US20080004298 3-hydroxypropylsulfamic acid {5-(4-bromophenyl)-6-[2-(5-bromoprimidin-2-yloxy)-ethoxy]-pyrimidin-4-yl}-amide, used for treatment of hypertension, congestive heart failure, renal and myocardial ischemia, renal failure, ischemia, dementia, headaches, hemorrhage, Raynaud's syndrome and ulcers |
| 01/03/2008 | US20080004297 Compounds and therapeutical use thereof |
| 01/03/2008 | US20080004296 Organic Compounds |
| 01/03/2008 | US20080004295 Novel compounds |
| 01/03/2008 | US20080004294 Heterocyclic compounds |
| 01/03/2008 | US20080004293 Adenosine receptor antagonists and methods of making and using the same |
| 01/03/2008 | US20080004292 Substituted 8-[6-amino-3-pyridyl]xanthines |
| 01/03/2008 | US20080004291 Compositions of 5-ht3 antagonists and dopamine d2 antagonists for treatment of dopamine-associated chronic conditions |
| 01/03/2008 | US20080004290 Anti-Cancer Agents |
| 01/03/2008 | US20080004289 Glycine transporter-1 inhibitors |
| 01/03/2008 | US20080004288 Indazole Sulphonamide Derivatives |
| 01/03/2008 | US20080004287 Human Double Minute 2 (HDM2) protein inhibitors; anticancer agents |
| 01/03/2008 | US20080004286 Inhibiting Human Double Minute 2 (HDM2) protein using 3-aminocarbonyl-3-phenoxy-1-(carbonyl or benzyl) piperidine compounds; use in combination with other anticancer agents or therapies |
| 01/03/2008 | US20080004285 Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment |
| 01/03/2008 | US20080004284 Method for treating fibromyalgia syndrome and related conditions |